An opportunity to increase human papillomavirus vaccination rates: Change the guidelines
A Aragones, F Gany, A Kaplan… - Human Vaccines & …, 2022 - Taylor & Francis
Given the low rates of Human Papillomavirus (HPV) vaccination initiation and timely series
completion in 11-and 12-year old children, we sought to assess potential opportunities for …
completion in 11-and 12-year old children, we sought to assess potential opportunities for …
[HTML][HTML] HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a …
V Osmani, S Fett, M Tauscher, E Donnachie… - BMC cancer, 2022 - Springer
Background Although the human papillomavirus (HPV) vaccine has been recommended in
Germany for girls since 2007, no organised vaccination programme was introduced and …
Germany for girls since 2007, no organised vaccination programme was introduced and …
Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007 …
HM Bauer, G Wright, J Chow - American journal of …, 2012 - ajph.aphapublications.org
Because of the rapid development of genital warts (GW) after infection, monitoring GW
trends may provide early evidence of population-level human papillomavirus (HPV) vaccine …
trends may provide early evidence of population-level human papillomavirus (HPV) vaccine …
Burden of human papillomavirus infection and related diseases in Israel
O Shavit, E Roura, M Barchana, M Diaz, J Bornstein - Vaccine, 2013 - Elsevier
This manuscript provides the available data on the burden of human papillomavirus (HPV)
infections and HPV-related diseases in Israel. The incidence of cervical intraepithelial …
infections and HPV-related diseases in Israel. The incidence of cervical intraepithelial …
Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
SE Goldstone - Human Vaccines & Immunotherapeutics, 2023 - Taylor & Francis
The risk for acquiring human papillomavirus (HPV) infections and associated diseases is
lifelong. An important part of prophylactic HPV vaccine development is durable protection …
lifelong. An important part of prophylactic HPV vaccine development is durable protection …
HPV vaccine acceptance, utilization and expected impacts in the US: Where are we now?
AF Dempsey, DA Patel - Human Vaccines, 2010 - Taylor & Francis
Human papillomavirus (HPV) vaccines represent a remarkable opportunity for the primary
prevention of cervical cancer and other HPV-related diseases. With almost four years of …
prevention of cervical cancer and other HPV-related diseases. With almost four years of …
Prevalence and incidence of HPV genital infection in women
C Velicer, X Zhu, S Vuocolo, KL Liaw… - Sexually transmitted …, 2009 - journals.lww.com
Background: A prophylactic quadrivalent human papillomavirus (HPV) vaccine could benefit
adult women if they are susceptible to incident genital HPV infections and are acquiring new …
adult women if they are susceptible to incident genital HPV infections and are acquiring new …
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
M Brisson, N Van de Velde, P De Wals, MC Boily - Vaccine, 2007 - Elsevier
AIM: Clinical trials have shown prophylactic human papillomavirus (HPV) vaccines to be
effective against infection and disease. We examined whether HPV vaccination has the …
effective against infection and disease. We examined whether HPV vaccination has the …
Prevalence of oral human papillomavirus infection by number of vaccine doses among US adults
MK Abel, AK Mann, K Sonawane, DS Kapp… - JNCI Cancer …, 2021 - academic.oup.com
The human papillomavirus (HPV) vaccine is effective at reducing the incidence of cervical
cancer caused by HPV. Studies have shown that 1 dose of the HPV vaccine offers …
cancer caused by HPV. Studies have shown that 1 dose of the HPV vaccine offers …
Physician attitudes and practice toward human papillomavirus vaccination
Objective: To compare physician practices, attitudes, and barriers toward human
papillomavirus (HPV) vaccination. Materials and Methods: A Web-based survey that …
papillomavirus (HPV) vaccination. Materials and Methods: A Web-based survey that …